Incidence of ventricular arrhythmias in patients with severe left ventricular systolic dysfunction: Is there a benefit after cardiac resynchronization therapy?;Incidência de arritmias ventriculares em doentes com disfunção sistólica ventricular esquerda grave: Existe benefício após terapêutica de ressincronização cardíaca

Revista Portuguesa de Cardiologia

Volumn 30, Issue 11, 2011, Pages 823-828

  Timóteo, Ana Teresa ^a   Oliveira, Mário Martins ^a   Silva, Manuel Nogueira ^a   Toste, Alexandra ^a   Ramos, Ruben ^a   Feliciano, Joana ^a   Cunha, Pedro Silva ^a   Soares, Rui ^a   Santos, Sofia ^a   Ferreira, Rui Cruz ^a  

^a HOSPITAL DE SANTA MARTA   (Portugal)

Author keywords

Cardiac resynchronization therapy; Heart failure; Implantable cardioverter defibrillator; Ventricular tachyarrhythmias

Indexed keywords

ADULT; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; DEFIBRILLATOR; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE SYSTOLIC DYSFUNCTION; HEART VENTRICLE ARRHYTHMIA; HUMAN; INCIDENCE; ISCHEMIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MORTALITY; PREVALENCE; SYSTOLIC DYSFUNCTION;

EID: 84855662122     PISSN: 08702551     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.repc.2011.09.004     Document Type: Article

References (26)

1. The Antiarrhythmic Versus Implantable Defibrillation (AVID) Investigators. A comparison of antiarrhythmic drug therapy with implantable defibrillator in patients resuscitated from near-fatal ventricular arrhythmia. N Engl J Med. 1997;337:1576-83.
2. Conolly SJ, Gent M, Roberts RS, et al. Canadian Implantable Defibrillator Study (CIDS): A randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation. 2000;101:1297-302. (Pubitemid 30158618)
3. Moss AJ, Hall NJ, Cannom DS, et al., MADIT Investigators. Improved survival with an implantable defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med. 1996;335:1933-40. (Pubitemid 26428217)
4. Greenberg H, Case RB, Moss AJ, et al. Analysis of mortality events in the MADIT-II trial. J Am Coll Cardiol. 2004;43:1459-65.
5. Cowie M, Mostard A, Wood D, et al. The epidemiology of heart failure. Eur Heart J. 1997;18:208-23.
6. Abraham WT, Fisher WG, Smith AL, et al., for the MIRACLE Study Group. Multicenter InSync Randomized Clinical Evaluation. Cardiac Resynchronization in chronic heart failure. N Engl J Med. 2002;346:1845-53. (Pubitemid 34603028)
7. Cleland JG, Daubert JC, Erdmann E, et al., Cardiac Resynchronization- Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352:1539-49. (Pubitemid 40517094)
8. Rivero-Ayerza M, Theuns DA, Garcia-Garcia HM, et al. Effects of cardiac resynchronization therapy on overall mortality and mode of death: a meta-analysis of randomized controlled trials. Eur Heart J. 2006;27:2682-8. (Pubitemid 44729869)
9. Bristow MR, Saxon LA, Boehmer J, et al. Cardiac resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350:2140-50.
10. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877-83. (Pubitemid 34984635)
11. Bardy G, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225-37. (Pubitemid 40110811)
12. Shukla G, Chaudhry GM, Orlov M, et al. Potential proarrhythmic effect of biventricular pacing: fact or myth? Heart Rhythm. 2005;2:951-6. (Pubitemid 41372282)
13. Medina-Ravell VA, Lankipalli RS, Yan GX, et al. Effect of epicardial or biventricular pacing to prolong QT interval and increase transmural dispersion of repolarization. Does resynchronization therapy pose a risk for patients predisposed to long QT or torsade de pointes? Circulation. 2003;107:740-6. (Pubitemid 36222603)
14. Rivero-Ayerza M, Vanderheyden M, Verstreken S, et al. Images in cardiovascular medicine. Polymorphic ventricular tachycardia induced by left ventricular pacing. Circulation. 2004;109:2924-5. (Pubitemid 38780309)
15. Zagrodzky JO, Ramaswany K, Page RL, et al. Biventricular pacing decreases the inducibility of ventricular tachycardia in patients with ischemic cardiomyopathy. Am J Cardiol. 2001;87:1208-10. (Pubitemid 32453247)
16. Higgins SL, Young P, Sheck D, et al., Ventak CHF Investigators. Biventricular pacing diminishes the need for implantable cardioverter defibrillator therapy. J Am Coll Cardiol. 2000;36:824-7.
17. Kies P, Bax JJ, Molhoek G, et al. Effect of left ventricular remodeling after cardiac resynchronization therapy on frequency of ventricular arrhythmias. Am J Cardiol. 2004;94:130-2.
18. Leyva F, Foley P. Is cardiac resynchronization therapy proarrhythmic? Indian Pacing Electrophysiol J. 2008;8:268-80.
19. Ray IB, Fenlander L, Singh JP. Cardiac resynchronization therapy and its potential proarrhythmic effect. Clin Cardiol. 2007;30:498-502. (Pubitemid 47587502)
20. Stockburger M, Nitardy A, Fateh-Moghadam S, et al. Electrical remodeling and cardiac dimensions in patients treated by cardiac resynchronization and heart failure controls. Pacing Clin Electrophysiol. 2008;31:70-7.
21. Theuns D, Thornton A, Klootwijk P, et al. Outcome in patients with an ICD incorporating cardiac resynchronisation therapy: differences between primary and secondary prophylaxis. Eur J Heart Fail. 2005;7:1027-32. (Pubitemid 41443598)
22. Lepillier A, Piot O, Gerritse B, et al. Relationship between New York Heart Association class change and ventricular tachyarrhythmia occurrence in patients treated with cardiac resynchronization plus defibrillator. Europace. 2009;11:80-5.
23. Saxon LA, Bristow MR, Boehmer J, et al. Predictors of sudden death and appropriate shock in the Comparison of Medical Therapy. Pacing, and Defibrillation in Heart Failure (COMPANION) trial. Circulation. 2006;114:2766-72. (Pubitemid 46018278)
24. Lin G, Rea HF, Hammill SC, et al. Effect of cardiac resynchronisation therapy on occurrence of ventricular arrhythmia in patients with implantable cardioverter defibrillators undergoing upgrade to cardiac resynchronisation therapy devices. Heart. 2008;94:186-260.
25. Timóteo AT, Galrinho A, Branco LM, et al. Variáveis ecocardiográficas predizentes de terapêuticas apropriadas de taquidisritmias ventriculares em doentes submetidos a terapêutica de ressincronização cardíaca combinada. Rev Port Cardiol. 2010;29:1009-19.
26. Cleland JGF, Daubert JC, Erdmann E, et al. Longer-term effect of cardiac resynchronization therapy on mortality in heart failure (The CARE-HF trial extension phase). Eur Heart J. 2006;27:1928-32. (Pubitemid 44297365)